
Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.
Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.
IMPs for immunotherapeutics require a different mindset, effective strategies, and meticulous planning, among other things, says KCR Trial Execution and Consulting.
Published: June 4th 2020 | Updated:
Published: August 13th 2020 | Updated: